Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Clinical Nutrition

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3945/ajcn.110.008557PMID 21775562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Prescription Omega-3-Acid Ethyl Esters on Fasting Lipid Profile in Subjects With Primary Hypercholesterolemia

  2011cited by this paper
• Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.

  2011cited by this paper
• N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention.

  2010cited by this paper
• Impact of Fish Oil-Based Lipid Emulsion on Serum Triglyceride, Bilirubin, and Albumin Levels in Children With Parenteral Nutrition-Associated Liver Disease

  2010cited by this paper
• Parenteral Fish Oil as Monotherapy Prevents Essential Fatty Acid Deficiency in Parenteral Nutrition–dependent Patients

  2010cited by this paper
• Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.

  2010cited by this paper
• Effects of fish oil supplementation on markers of the metabolic syndrome.

  2010cited by this paper
• Parenteral nutrition in the critically ill patient.

  2010cited by this paper
• Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome

  2010cited by this paper
• Parenteral nutrition in the critically ill patient.

  2010cited by this paper
• Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

  2009cited by this paper
• Impact of Fish Oil-Based Lipid Emulsion on Serum Triglyceride, Bilirubin, and Albumin Levels in Children With Parenteral Nutrition-Associated Liver Disease

  2009cited by this paper
• Alteration of lipid fatty acid profile and cationic fluxes in ventricular cardiomyocytes from ω3-depleted rats

  2009cited by this paper
• Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver Injury

  2009cited by this paper
• Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications.

  2008cited by this paper
• Safety and Efficacy of a Fish-Oil–Based Fat Emulsion in the Treatment of Parenteral Nutrition–Associated Liver Disease

  2008cited by this paper
• Alteration of lipid fatty acid profile and cationic fluxes in ventricular cardiomyocytes from omega3-depleted rats.

  2008cited by this paper
• Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.

  2007cited by this paper
• Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II

  2007cited by this paper
• Reversal of Parenteral Nutrition–Associated Liver Disease in Two Infants With Short Bowel Syndrome Using Parenteral Fish Oil: Implications for Future Management

  2006cited by this paper
• The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects--A randomized, placebo-controlled, double-blind study.

  2006cited by this paper
• Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study.

  2006cited by this paper
• Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.

  2006cited by this paper
• Current clinical applications of omega-6 and omega-3 fatty acids.

  2006cited by this paper
• Current Clinical Applications of Ω-6 and Ω-3 Fatty Acids.

  2006cited by this paper
• Comparative Effect of Fish Oil Feeding and Other Dietary Fatty Acids on Plasma Lipoproteins, Biliary Lipids, and Hepatic Expression of Proteins Involved in Reverse Cholesterol Transport in the Rat

  2005cited by this paper
• Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition.

  2005cited by this paper
• The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia.

  2003cited by this paper
• Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals.

  2003cited by this paper
• Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.

  2001cited by this paper
• ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.

  2000cited by this paper
• Metabolic and monetary costs of avoidable parenteral nutrition use.

  1999cited by this paper
• Development of fat emulsions.

  1999cited by this paper
• Biochemical markers of dietary intake.

  1997cited by this paper
• Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest.

  1995cited by this paper
• The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models.

  1995influential reference
• Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation.

  1995influential reference
• Effects of dietary purified eicosapentaenoic acid (20:5 (n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells.

  1992influential reference
• Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits.

  1992cited by this paper
• Biological markers of diet.

  1987cited by this paper
• Longitudinal data analysis for discrete and continuous outcomes.

  1986cited by this paper
• Alteration of lipoprotein profile during total parenteral nutrition with intralipid 10%.

  1986cited by this paper
• On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.

  1985influential reference
• The inverse relation between fish consumption and 20-year mortality from coronary heart disease.

  1985cited by this paper
• Invited Review: Development of Fat Emulsions

  1981cited by this paper
• Effect of sex and age on fatty acid composition of human serum lipids.

  1979cited by this paper

• Essential fatty acid deficiency in children treated with long-term 100% fish-oil lipid injectable emulsion: A longitudinal descriptive cohort study.

  2025cites this paper
• Nutritional management after necrotizing enterocolitis and focal intestinal perforation in preterm infants.

  2024cites this paper
• Effect of parenteral lipids on essential fatty acid deficiency in pediatric intestinal failure: A retrospective cohort study.

  2024cites this paper
• Dietary Implications of Polyunsaturated Fatty Acids during Pregnancy and in Neonates

  2023cites this paper
• Clinical and neurodevelopmental outcomes in premature infants exposed to intravenous fish- and soybean oil-based lipid emulsions

  2023cites this paper
• Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids.

  2022cites this paper
• Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm PN-fed pigs.

  2021cites this paper
• Parenteral Nutrition and Oxidant Load in Neonates

  2021cites this paper
• Neonatal Hepatitis

  2021cites this paper
• Short Bowel Syndrome in an Infant.

  2020cites this paper
• Reporting on outcome measures in pediatric chronic intestinal failure: A systematic review.

  2020cites this paper
• Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications

  2020cites this paper
• Use of Fish Oil Intravenous Lipid Emulsions as Monotherapy in the Pediatric Intestinal Failure Patient: Beyond the Package Insert.

  2020cites this paper
• Rifampicin, Not Vitamin E, Suppresses Parenteral Nutrition Associated Liver Disease Development through Pregnane X Receptor Pathway in Piglets.

  2019cites this paper
• Physiological Change of Serum Bilirubin Level by ω-3 Enriched Parenteral Nutrition Versus ω-3 Free Parenteral Nutrition in Healthy Male Subjects

  2019cites this paper
• Nutrition for the Surgical Neonate

  2019cites this paper
• New Lipid Strategies to Prevent/Treat Neonatal Cholestasis

  2019cites this paper
• Lipid and Fatty Acid Delivery in the Preterm Infant

  2019cites this paper
• Intravenous Fish Oil and Serum Fatty Acid Profiles in Pediatric Patients With Intestinal Failure-Associated Liver Disease.

  2019cites this paper
• Current status of lipid emulsions in the prevention of intestinal failure-associated liver disease

  2019cites this paper
• ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Vitamins.

  2018cites this paper
• ESPR guidelines on pediatric parenteral nutrition : Complications

  2018cites this paper
• Visceral transplantation in patients with intestinal‐failure associated liver disease: Evolving indications, graft selection, and outcomes

  2018cites this paper
• Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency

  2018cites this paper
• ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Complications.

  2018cites this paper
• ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids.

  2018cites this paper
• Gastrointestinal Development: Implications for Management of Preterm and Term Infants.

  2018cites this paper
• A detailed guide to lipid therapy in intestinal failure.

  2018cites this paper
• Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.

  2018cites this paper
• Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure–Associated Liver Disease

  2017cites this paper
• Higher Doses of Fish Oil–Based Lipid Emulsions Used to Treat Inadequate Weight Gain and Rising Triene: Tetraene Ratio in a Severely Malnourished Infant With Intestinal Failure–Associated Liver Disease

  2017cites this paper
• 92 – Digestive-Absorption Functions in Fetuses, Infants, and Children

  2017cites this paper
• Characterization of Fatty Acid Profiles in Infants With Intestinal Failure–Associated Liver Disease

  2017cites this paper
• Predictive factors of hypertriglyceridemia in inhospital patients during total parenteral nutrition

  2017cites this paper
• Enteral High Fat‐Polyunsaturated Fatty Acid Blend Alters the Pathogen Composition of the Intestinal Microbiome in Premature Infants with an Enterostomy

  2017cites this paper
• Intestinal Hypoganglionosis Leading to Intestinal Failure and the Compassionate Use of Omegaven™

  2017cites this paper
• Is OM-3 synergistic with GLP-2 in intestinal failure?

  2017cites this paper
• Intravenous lipid emulsions in pediatric patients with intestinal failure

  2017cites this paper
• Predictors of a successful outcome for infants with short bowel syndrome: a 30-year single-institution experience

  2017cites this paper
• Parenteral Nutrition and Lipids

  2017cites this paper
• Intravenous Fish Oil and Pediatric Intestinal Failure–Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids

  2017cites this paper
• Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.

  2016cites this paper
• Low-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.

  2016influential citation
• Double blind exploratory study on de novo lipogenesis in preterm infants on parenteral nutrition with a lipid emulsion containing 10% fish oil.

  2016cites this paper
• A Product Review of Alternative Oil-Based Intravenous Fat Emulsions.

  2016cites this paper
• Working group reports: evaluation of the evidence to support practice guidelines for nutritional care of preterm infants—the Pre-B Project1–4

  2016cites this paper
• Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.

  2016cites this paper
• Mucous fistula refeeding in neonates with enterostomies.

  2015cites this paper
• Proceedings From FDA/A.S.P.E.N. Public Workshop: Clinical Trial Design for Intravenous Fat Emulsion Products, October 29, 2013.

  2015cites this paper
• Parenteral lipids and partial enteral nutrition affect hepatic lipid composition but have limited short term effects on formula-induced necrotizing enterocolitis in preterm piglets.

  2015cites this paper
• Impact of Providing a Combination Lipid Emulsion Compared With a Standard Soybean Oil Lipid Emulsion in Children Receiving Parenteral Nutrition: A Systematic Review and Meta-Analysis.

  2015cites this paper
• Intravenous Lipid Emulsions in Parenteral Nutrition.

  2015cites this paper
• Lipids and Fatty Acids in the Preterm Infant, Part 2: Clinical Considerations

  2015cites this paper
• Mucous fistula refeeding decreases parenteral nutrition exposure in postsurgical premature neonates.

  2015cites this paper
• STUDY OF FXR IN PRIMARY HUMAN HEPATOCYTES AND FXR REGULATED BA HOMEOSTASIS IN PARENTERAL NUTRITION ASSOCIATED LIVER DISEASES By Copyright 2014

  2014cites this paper
• Use of Fish Oil–Based Lipid Emulsions in Infants With Intestinal Failure–Associated Liver Disease

  2014influential citation
• Short Bowel Syndrome in Childhood

  2014cites this paper
• Nutrition in Children with Liver Disease: Evaluation and Management

  2014cites this paper
• Recent advances in the management of pediatric intestinal failure.

  2014cites this paper
• Clinical Guidelines : Support of Pediatric Patients With Intestinal Failure at Risk of Parenteral Nutrition – Associated Liver Disease

  2014cites this paper
• Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.

  2014cites this paper
• Understanding Triglyceride Levels Related to Intravenous Fat Administration

  2014cites this paper
• A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease.

  2014cites this paper
• Clinical Guidelines : Support of Pediatric Patients With Intestinal Failure at Risk of Parenteral

  2014cites this paper
• Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

  2014cites this paper
• Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure

  2014cites this paper
• Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion.

  2013cites this paper
• Associated Liver Disease in Infants and Children : A Systematic Review − Failure Associated Cholestasis and Intestinal − Incidence , Prevention , and Treatment of Parenteral Nutrition

  2013cites this paper
• The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model.

  2013cites this paper
• Intravenous Lipids in Neonates

  2013cites this paper
• FATTY ACIDS IN NUTRITION SOURCES FOR PRETERM INFANTS

  2013cites this paper
• Optimal oxygen saturations in preterm infants: a moving target

  2013cites this paper
• Effect of emulsified isoflurane on apoptosis of anoxia-reoxygenation neonatal rat cardiomyocytes.

  2013cites this paper
• Short-term intravenous fish oil and pediatric intestinal failure associated liver disease: 3-year follow-up on liver function and nutrition.

  2013cites this paper
• Effects of Parenteral Nutrition Formulas on Plasma Lipid Profile in Children with Bone Marrow Transplantation

  2013cites this paper
• Experimental Evidence of ω-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic Diseases

  2013cites this paper
• Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease

  2013cites this paper
• Intestinal Crises in the Newborn : Loss of Intestinal Absorptive Capacity after Necrotizing Enterocolitis

  2012influential citation
• The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)

  2012cites this paper
• Parenteral lipid administration to very-low-birth-weight infants--early introduction of lipids and use of new lipid emulsions: a systematic review and meta-analysis.

  2012influential citation
• Parenteral fish-oil–based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition–dependent children

  2012cites this paper
• Pathogenesis and treatment of parenteral nutrition-associated liver disease.

  2012cites this paper
• Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.

  2012cites this paper
• The use of alternative lipid emulsions in paediatric and neonatal parenteral nutrition

  2011cites this paper